Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19621118 | 0.81 | LMNA (0.50) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL7057576 | 0.78 | LMNA (0.51) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL178864 | 0.75 | ALDH1A1 (0.42) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL20370331 | 0.75 | MAPT (0.51) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL24531686 | 0.73 | ALDH1A1 (0.44) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL14838496 | 0.73 | ALDH1A1 (0.45) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL107302 | 0.73 | MAPT (0.42) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL2241228 | 0.71 | ALDH1A1 (0.50) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL24281920 | 0.71 | GAA (0.45) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL12459980 | 0.71 | MAPT (0.41) | ALDH1A1KMT2AMEN1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077801-B2 | Regioselective hydroxylation of isophorone | DSM IP ASSETS B.V. (NL) | 2024-09-03 | — | — | US | disclosed |
| US-20210108234-A1 | REGIOSELECTIVE HYDROXYLATION OF ISOPHORONE | DSM IP ASSETS B.V. (NL) | 2021-04-15 | — | — | US | disclosed |
| EP-3607076-A1 | REGIOSELECTIVE HYDROXYLATION OF ISOPHORONE AND FURTHER CONVERSION TO KETOISOPHORONE | DSM IP Assets B.V. (NL) | 2020-02-12 | — | — | EP | disclosed |
| WO-2018185304-A1 | REGIOSELECTIVE HYDROXYLATION OF ISOPHORONE AND FURTHER CONVERSION TO KETOISOPHORONE | DSM IP ASSETS B.V. (NL) | 2018-10-11 | — | — | WO | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| US-7276622-B2 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-02 | — | — | US | disclosed |
| EP-1797953-A1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20060173221-A1 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1609777-A1 | METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2005-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | ALDH1A1 36/4885KMT2A 1283/4885MEN1 2767/4885 |
| US-20060173221-A1 | Method for producing oxygen-containing compound | GPX4, DUOX2, SCO2 | ALDH1A1 863/4885KMT2A 2326/4885MEN1 2707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.